Bingxian Xie

University of Pittsburgh — United States

Medicine · Health Sciences

24h-index2.0kcitations104works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adipose Tissue and Metabolism(17), Mitochondrial Function and Pathology(12), Metabolism, Diabetes, and Cancer(11), Pancreatic function and diabetes(10), Immune Cell Function and Interaction(10)

Publications104 total

Figure 1 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S10 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S11 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Figure 2 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S1 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S7 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S4 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S12 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Tables S1-4 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Figure 4 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Figure 6 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Appendix 4 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S6 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S8 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Appendix 2 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S5 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Appendix 1 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Data from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Figure 5 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
Supplementary Fig S2 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
2025Open Access
page 1 of 6Next →

Frequent Co-authors

Michael J. Jurczak(20), Iain Scott(13), Greg M. Delgoffe(11), Shuai Chen(11), Janet R. Manning(11), Dharendra Thapa(10), Michael W. Stoner(9), Hong Yu Wang(9), Ian Sipula(8), Manling Zhang(8), Chao Quan(8), Lia R. Edmunds(7), Qiaoli Chen(7), Ronal M. Peralta(5), Konstantinos Lontos(5), Dayana B. Rivadeneira(5), Sheng Yang(5), Amanda M. Mills(5), Paramesha Bugga(5), Bellina A.S. Mushala(5)